• Explore /
  • Poster
  • / Pembrolizumab (pembro) in microsatellite instability-high (MSI-H) advanced gastric/gastroesophageal junction (G/GEJ) cancer by line of therapy.

Pembrolizumab (pembro) in microsatellite instability-high (MSI-H) advanced gastric/gastroesophageal junction (G/GEJ) cancer by line of therapy.

Abstract Poster

Authors

null

Joseph Chao

City of Hope Comprehensive Cancer Center, Duarte, CA

Joseph Chao , Charles S. Fuchs , Kohei Shitara , Josep Tabernero , Kei Muro , Eric Van Cutsem , Yung-Jue Bang , Ferdinando De Vita , Greg A. Landers , Chia-Jui Yen , Ian Chau , Anneli Elme , Jeeyun Lee , Mustafa Ozguroglu , Daniel V.T. Catenacci , Xiaodong Li , Chie-Schin Shih , Sukrut Shah , Pooja Bhagia , Zev A. Wainberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

(KN)-059 (NCT02335411), KN061 (NCT02370498), and KN062 (NCT02494583)

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 430)

Abstract #

430

Poster Bd #

G19

Abstract Disclosures

Similar Posters

First Author: Sun Young Rha

First Author: Josep Tabernero

First Author: Hironaga Satake

First Author: Sun Young Rha